Minerva Surgical Launches Educational Website for Women Living with Abnormal Uterine Bleeding

Rhea-AI Summary

Minerva Surgical has launched AUBandMe.com at the 50th Global Congress of the American Association of Gynecologic Laparoscopists, focusing on Abnormal Uterine Bleeding (AUB) treatment education. AUB affects 1 in 3 women, often leading to untreated conditions and significant quality of life deterioration. The initiative aims to empower women with knowledge about available non-hormonal treatments and improve their treatment options. CEO Dave Clapper emphasized the need for better awareness and solutions for women suffering from heavy periods.

Positive

• Launch of AUBandMe.com aims to educate women about AUB and available treatments.
• Focus on non-hormonal, minimally invasive treatment options.
• Potential to improve the quality of life for women suffering from AUB.

Negative

• 41% of surveyed women believe there are no treatment options for AUB.
• AUB often leads to hysterectomy, increasing risks of coronary artery disease.

AUBandMe.com debuts at the American Association of Gynecologic Laparoscopists 50th Global Congress

SANTA CLARA, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a women's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announces today the launch of a new consumer education experience for women: www.aubandme.com. The company is showcasing the website at the American Association of Gynecologic Laparoscopists (AAGL) 50^th Global Congress in Austin, Texas, on November 15 – 17, 2021.

AUB is a serious condition affecting 1 in 3 women and is often untreated.¹ In the prime of their lives, with significant personal and professional responsibilities, millions of women shoulder the additional burden of pain, heavy bleeding, fatigue, depression and infertility – some of the symptoms associated with AUB. Those living with AUB reported a quality of life score below the 25^th percentile of the general population.²

“We spoke with women across the country and they were clear: they lack access to complete and accurate information about their uterus. When women learn about AUB, we see the light go on. Women have been suffering for so long and once they learn about fibroids, polyps and other common causes of AUB, they feels confident about speaking with her doctor. AUBandMe.com puts women on the pathway to wellness,” said Eugene Skalnyi, M.D., Vice President of Medical Affairs.

For too long, women have been discouraged from discussing their heavy periods. They suffer in silence, unaware that non-hormonal, minimally invasive treatment options are available. A 2020 survey of over 6,000 women who were either diagnosed with AUB or felt their periods were heavier than normal, showed that 41% believed there were no treatment options available to them.³

This common condition often results in a hysterectomy which can lead to other negative impacts on health, including a 33% increased risk of coronary artery disease.³

Dave Clapper, President and CEO said, “We must do a better job of prioritizing women’s experience with their heavy periods. By increasing awareness and treatment options for AUB, women will have the opportunity to be freed of the debilitating symptoms and significantly improve their quality of life. When women, their families, and communities benefit, we all benefit. That’s our motivation behind the creation of AUBandMe.”

FOOTNOTES

1. Spencer CP, Whitehead MI. Endometrial Assessment Re-visited. Br J Obstet Gynaecol. 1999 Jul;106(7):623-32. doi: 10.1111/j.1471-0528.1999.tb08358.x. PMID: 10428515.
2. Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health. 2007 May-Jun;10(3):183-94. doi: 10.1111/j.1524-4733.2007.00168.x. PMID: 17532811.
3. Laughlin-Tommaso SK, et al. Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study. Menopause. 2018 May;25(5):483-492. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898981/pdf/nihms918518.pdf.
   

ABOUT MINERVA SURGICAL – THE UTERINE HEALTH COMPANY

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

MEDIA CONTACT

Mike Clapper
mike.clapper@minervasurgical.com
804-295-7676

RELATED LINKS

https://www.aubandme.com

https://www.minervasurgical.com

FAQ

What is the purpose of AUBandMe.com launched by Minerva Surgical?

AUBandMe.com aims to educate women about Abnormal Uterine Bleeding and available treatment options.

What condition does AUBandMe.com address?

AUBandMe.com addresses Abnormal Uterine Bleeding, affecting 1 in 3 women.

When was AUBandMe.com launched?

AUBandMe.com was launched during the AAGL 50th Global Congress on November 15-17, 2021.

How does AUB affect women's health?

AUB can lead to pain, heavy bleeding, fatigue, and even infertility, significantly impacting women's quality of life.